Brian Ference
Institute for Advanced Studies, University of Bristol, 3rd Floor, Senate House, Bristol BS8 1UH, UK. Electronic address: bference@med.wayne.edu
Marelli-Berg FM.
William Harvey Research Institute, Queen Mary University of London, London EC1M6BQ, UK.
• Center for hepatology and metabolic diseases – Ospedale Maggiore Policlinico IRCCS, Università degli studi di Milano
Detection of markers of hepatic steatosis and correlation with cardio-metabolic and atherosclerosis markers in the general population
• Istituto di Tecnologie Biomediche – Consiglio Nazionale delle Ricerche
Study of the associative and causal role of microbiome alterations and cardiovascular disease in humans
• REPROGRAM project (Horizon H2020-PHC-2015-two-stage)
Epigenetic mechanisms and reprogramming of innate immune cells in atherosclerosis management and other chronic inflammatory diseases
• William Harvey Research Institute – Queen Mary University London (UK) (Professor Federica Marelli-Berg)
Interplay between sistemic/cellular metabolism and adaptive immune response.
• Humanitas Research Institute – Rozzano (Mi) (Professor Marinos Kallikourdis)
“Engineered regulatory T cell Adoptive Cell Therapy as a novel tool for the treatment of Cardiovascular diseases”
• Humanitas Research Institute – Rozzano (Mi) (Dr. Cecilia Garlanda and Professor Barbara Bottazzi)
Role of the long pentraxin 3 in cardiometabolic diseases
• Department of Pharmacological and Biomolecular Science – University of Milan (Professor Nico Mitro)
Role of role fatty acid synthesis in immune cell function
• Department of Pharmacological and Biomolecular Science – University of Milan (Professor Maurizio Crestani)
Role of histone deacetylase 3 (HDAC3) in cardiometabolic disease
